These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 31549359)

  • 1. A Need for Change! A Coding Framework for Improving Transparency in Decision Modeling.
    Alarid-Escudero F; Krijkamp EM; Pechlivanoglou P; Jalal H; Kao SZ; Yang A; Enns EA
    Pharmacoeconomics; 2019 Nov; 37(11):1329-1339. PubMed ID: 31549359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TECH-VER: A Verification Checklist to Reduce Errors in Models and Improve Their Credibility.
    Büyükkaramikli NC; Rutten-van Mölken MPMH; Severens JL; Al M
    Pharmacoeconomics; 2019 Nov; 37(11):1391-1408. PubMed ID: 31705406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Overview of R in Health Decision Sciences.
    Jalal H; Pechlivanoglou P; Krijkamp E; Alarid-Escudero F; Enns E; Hunink MGM
    Med Decis Making; 2017 Oct; 37(7):735-746. PubMed ID: 28061043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Avoiding and identifying errors in health technology assessment models: qualitative study and methodological review.
    Chilcott J; Tappenden P; Rawdin A; Johnson M; Kaltenthaler E; Paisley S; Papaioannou D; Shippam A
    Health Technol Assess; 2010 May; 14(25):iii-iv, ix-xii, 1-107. PubMed ID: 20501062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Procedures and methods of benefit assessments for medicines in Germany].
    Bekkering GE; Kleijnen J
    Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 7():S225-46. PubMed ID: 19034813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Flexible Open-Source Decision Model for Value Assessment of Biologic Treatment for Rheumatoid Arthritis.
    Incerti D; Curtis JR; Shafrin J; Lakdawalla DN; Jansen JP
    Pharmacoeconomics; 2019 Jun; 37(6):829-843. PubMed ID: 30737711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A pilot study on the use of decision theory and value of information analysis as part of the NHS Health Technology Assessment programme.
    Claxton K; Ginnelly L; Sculpher M; Philips Z; Palmer S
    Health Technol Assess; 2004 Jul; 8(31):1-103, iii. PubMed ID: 15248937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Model transparency and validation: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force--7.
    Eddy DM; Hollingworth W; Caro JJ; Tsevat J; McDonald KM; Wong JB;
    Value Health; 2012; 15(6):843-50. PubMed ID: 22999134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NeuroPycon: An open-source python toolbox for fast multi-modal and reproducible brain connectivity pipelines.
    Meunier D; Pascarella A; Altukhov D; Jas M; Combrisson E; Lajnef T; Bertrand-Dubois D; Hadid V; Alamian G; Alves J; Barlaam F; Saive AL; Dehgan A; Jerbi K
    Neuroimage; 2020 Oct; 219():117020. PubMed ID: 32522662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microsimulation Modeling for Health Decision Sciences Using R: A Tutorial.
    Krijkamp EM; Alarid-Escudero F; Enns EA; Jalal HJ; Hunink MGM; Pechlivanoglou P
    Med Decis Making; 2018 Apr; 38(3):400-422. PubMed ID: 29587047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Achieving Appropriate Model Transparency: Challenges and Potential Solutions for Making Value-Based Decisions in the United States.
    Carlson JJ; Walton SM; Basu A; Chapman RH; Campbell JD; McQueen RB; Pearson SD; Touchette DR; Veenstra D; Whittington MD; Ollendorf DA
    Pharmacoeconomics; 2019 Nov; 37(11):1321-1327. PubMed ID: 31485925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Now Is the Time for Transparency in Value-Based Healthcare Decision Modeling.
    Hay JW
    Value Health; 2019 May; 22(5):564-569. PubMed ID: 31104735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
    Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
    Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implementation Barriers to Value of Information Analysis in Health Technology Decision Making: Results From a Process Evaluation.
    Grimm SE; Pouwels X; Ramaekers BLT; van Ravesteyn NT; Sankatsing VDV; Grutters J; Joore MA
    Value Health; 2021 Aug; 24(8):1126-1136. PubMed ID: 34372978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer diagnostic tools to aid decision-making in primary care: mixed-methods systematic reviews and cost-effectiveness analysis.
    Medina-Lara A; Grigore B; Lewis R; Peters J; Price S; Landa P; Robinson S; Neal R; Hamilton W; Spencer AE
    Health Technol Assess; 2020 Nov; 24(66):1-332. PubMed ID: 33252328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Developing Open-Source Models for the US Health System: Practical Experiences and Challenges to Date with the Open-Source Value Project.
    Jansen JP; Incerti D; Linthicum MT
    Pharmacoeconomics; 2019 Nov; 37(11):1313-1320. PubMed ID: 31392665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. When is enough evidence enough? - Using systematic decision analysis and value-of-information analysis to determine the need for further evidence.
    Siebert U; Rochau U; Claxton K
    Z Evid Fortbild Qual Gesundhwes; 2013; 107(9-10):575-84. PubMed ID: 24315327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.